WO2025215672 - "PROCESS FOR PREPARATION OF BLARCAMESINE"
National phase entry is expected:
Publication Number
WO/2025/215672
Publication Date
16.10.2025
International Application No.
PCT/IN2025/050573
International Filing Date
10.04.2025
Title **
[English]
"PROCESS FOR PREPARATION OF BLARCAMESINE"
[French]
PROCÉDÉ DE PRÉPARATION DE BLARCAMÉSINE
Applicants **
DR. REDDY’S LABORATORIES LIMITED
Inventors
REHANI BUDHDEV, Rajeev
KUMAR MADHRA, Mukesh
BANDICHHOR, Rakeshwar
DWARAMPUDI, Adi Reddy
KUMAR KODIDE, Santhosh
MADA, Mallikharjuna Rao
MUTYAM, Latchi Reddy
DEVARAKONDA, Aruna Kumar
THATIPAMULA, Sudhakar
SEERA, Raviteja
PAL DATTA, Sharmistha
Priority Data
202441029665
12.04.2024
IN
202441045749
13.06.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2202 | |
| EPO | Filing, Examination, Granting | 11876 | |
| Japan | Filing, Examination, Granting | 2124 | |
| South Korea | Filing, Examination, Granting | 2104 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
24,846
Contact Us
Abstract[English]
The present invention relates novel synthetic methods of Blarcamesine, its intermediate compounds, its pharmaceutically acceptable salts, and pharmaceutical compositions thereof. Further, the present invention relates to novel co-crystals of Blarcamesine Hydrochloride, their solid-state forms, their preparative methods, and pharmaceutical compositions thereof.[French]
La présente invention concerne de nouveaux procédés de synthèse de blarcamésine, de ses composés intermédiaires, de ses sels pharmaceutiquement acceptables et des compositions pharmaceutiques de ceux-ci. En outre, la présente invention concerne de nouveaux co-cristaux de chlorhydrate de blarcamésine, leurs formes à l'état solide, leurs procédés de préparation et des compositions pharmaceutiques de ceux-ci.